SerpinB2 May Curb Insulin Resistance and Prevent Diabetes

Feb 12, 2026 | Cardiology News, Endocrinology News, Featured

Led by Dr. Partha Dutta in the VMI, the study reveals how boosting protective fat-resident immune cells may prevent and even reverse type 2 diabetes. Read...

Opioid Use Disorder Care Presentations After High-deductible Health Plan Enrollment

Feb 10, 2026 | Uncategorized

J Addict Med. 2026 Feb 11. doi: 10.1097/ADM.0000000000001662. Online ahead of print.ABSTRACTOBJECTIVE: Determine whether employer-mandated transitions from low- to high-deductible health plans (HDHPs) are associated with delays in opioid use disorder (OUD)-related...

A Content Analysis of Xylazine-associated Stigma in Web-based Media Driven by the Zombie Term and Stigmatizing Imagery

Feb 8, 2026 | Uncategorized

J Addict Med. 2026 Jan-Feb 01;20(1):126-129. doi: 10.1097/ADM.0000000000001506. Epub 2025 May 14.ABSTRACTBACKGROUND: Drug use-related stigma amplifies the harms faced by people who use drugs (PWUD). Media often dehumanizes PWUD, particularly those using xylazine, a...

Navigating an Unpredictable Supply: Lived Experiences of Xylazine Exposure Among People Who Use Drugs

Feb 5, 2026 | Uncategorized

Res Sq [Preprint]. 2026 Jan 13:rs.3.rs-7199750. doi: 10.21203/rs.3.rs-7199750/v1.ABSTRACTBACKGROUND: As xylazine-adulterated opioids become more prevalent in the U.S., people who use drugs (PWUD) face growing risks from sedation, withdrawal, and wounds. This study...

Perspectives on Harm Reduction Kit Implementation in Heterogeneous Outpatient Clinics

Feb 5, 2026 | Uncategorized

Res Sq [Preprint]. 2026 Jan 25:rs.3.rs-6059606. doi: 10.21203/rs.3.rs-6059606/v1.ABSTRACTBackground: The evolving U.S. drug market has fueled a public health crisis with rising drug use-associated morbidity and mortality, revealing a mismatch between current...